From January 1, 2022 to March 31, 2022, the company has repurchased 4,478,900 shares, representing 0.82% for CNY 69.74 million. With this, the company has completed the repurchase of 11,355,900 shares, representing 2.09% for CNY 174.83 million under the buyback announced on August 4, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.14 CNY | -0.69% | -1.65% | +8.33% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.33% | 759M | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- 300497 Stock
- News Jiangxi Fushine Pharmaceutical Co., Ltd.
- Tranche Update on Jiangxi Fushine Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 4, 2021.